AIG
NPCE icon

American International Group’s Neuropace NPCE Stock Holding History

American International Group’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,525
Closed -$29K – 3210
2022
Q1 		$29K Sell
3,525
-248
-7% -$2.14K ﹤0.01% 2982
2021
Q4 		$38K Sell
3,773
-113
-3% -$1.47K ﹤0.01% 3020
2021
Q3 		$62K Sell
3,886
-16
-0.4% -$336 ﹤0.01% 2956
2021
Q2 		$93 Buy
+3,902
New +$90.6K ﹤0.01% 2892

Other funds holding NPCE

KL
KCK Ltd Hamilton, Bermuda $15.1M AUM 30.14% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
Revelation Capital Management Sausalito, California $67.4M AUM

American International Group's NPCE Position: Q2 2022 in Review

American International Group sold out of Neuropace (NPCE) in Q2 2022, closing a stake of 3,525 shares — an estimated $29K sold.

American International Group first reported a position in NPCE in Q2 2021 and held it in 4 quarters. The position peaked at $62K in Q3 2021. 32 funds tracked by Wall St. Rank hold NPCE as of Q2 2022.

  • American International Group reported no remaining Neuropace position as of Q2 2022 after selling out during the quarter.
  • American International Group sold 3,525 Neuropace shares in Q2 2022, an estimated $29K.
  • American International Group first reported a position in Neuropace in Q2 2021 and held it in 4 quarters.
  • American International Group's Neuropace position peaked at $62K in Q3 2021.
  • 32 funds tracked by Wall St. Rank held Neuropace as of Q2 2022.

Based on American International Group's 13F filing for Q2 2022, filed 12 Aug 2022.